New Jersey lawmakers took action recently to provide medical malpractice reform for physicians in the state. On June 7, the state's governor signed the New Jersey Medical Care Access and Responsibility and Patients First Act into law.
The new law creates a $78 million temporary fund to help cover the cost of insurance premiums, among other things, reported State Health Notes (6/14/04), a publication of the National Conference of State Legislatures. To raise money for the fund (set to expire in 3 years), the law imposes an annual surcharge of $75 on physicians, podiatrists, chiropractors, dentists, optometrists, and lawyers, as well as $3 per employee from all employers covered under the state's Unemployment Compensation Law.
State legislators earmarked $17 million to help pay the insurance premiums of those health-care providers who experience rate increases above a specified amount. Funds were also reserved to subsidize hospital charity care, a student loan expense reimbursement program for ob/gyns who practice in underserved areas for at least 4 years, and a program for pregnant women who do not qualify for Medicaid and cannot afford health care.
While the law does not provide caps on damages in malpractice lawsuits, it does allow physicians to join "purchasing alliances" to better negotiate insurance premiums for members, and it prevents insurers from raising clinicians' insurance rates if a medical malpractice claim against them is dismissed.
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Trimethoprim–sulfamethoxazole not found to increase infant birth weight in HIV cases
July 9th 2025A recent randomized trial found no significant improvement in birth weight or key birth outcomes from antenatal trimethoprim–sulfamethoxazole prophylaxis in human immunodeficiency virus-positive pregnant women.
Read More
Trimethoprim–sulfamethoxazole not found to increase infant birth weight in HIV cases
July 9th 2025A recent randomized trial found no significant improvement in birth weight or key birth outcomes from antenatal trimethoprim–sulfamethoxazole prophylaxis in human immunodeficiency virus-positive pregnant women.
Read More
2 Commerce Drive
Cranbury, NJ 08512